Mural Oncology Plc (MURA)

Dec 20, 2024

2025 will be a big year for Mural Oncology's drugs in development - The Business Journals

Dec 20, 2024

Dec 19, 2024

BNP Paribas Financial Markets Lowers Stake in Mural Oncology plc (NASDAQ:MURA) - Defense World

Dec 19, 2024

Dec 19, 2024

Mural Oncology stock hits 52-week low at $2.87 By Investing.com - Investing.com UK

Dec 19, 2024

Dec 18, 2024

Mural Oncology CEO Caroline Loew sells shares worth $9,394 - Investing.com

Dec 18, 2024

Dec 18, 2024

Mural Oncology CEO Caroline Loew sells shares worth $9,394 By Investing.com - Investing.com UK

Dec 18, 2024

Dec 09, 2024

Mural Oncology plc (NASDAQ:MURA) Shares Sold by Verition Fund Management LLC - MarketBeat

Dec 09, 2024

Dec 07, 2024

Mural Oncology GAAP EPS of -$1.84; reaffirms financial guidance - MSN

Dec 07, 2024

Dec 04, 2024

Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Dec 04, 2024

Dec 03, 2024

Mural Oncology Awards Key Talent with Stock Options and RSU Inducement Grants - StockTitan

Dec 03, 2024

Nov 25, 2024

Alkermes to Participate in Upcoming Investor Conferences - Quantisnow

Nov 25, 2024

Nov 24, 2024

Raymond James Predicts Up to ~440% Rally for These 2 ‘Strong Buy’ Stocks - Yahoo Finance

Nov 24, 2024

Nov 22, 2024

Rodman & Renshaw Initiates Coverage of Mural Oncology (MURA) with Buy Recommendation - MSN

Nov 22, 2024

Nov 21, 2024

Mural Oncology Announces Publication Highlighting Promising Clinical Antitumor Activity Shown in its ARTISTRY-1 Clinical Trial of Nemvaleukin, its Lead Engineered Fusion Protein, in the Journal for ImmunoTherapy of Cancer - The Manila Times

Nov 21, 2024

Nov 20, 2024

Mural Oncology's Cancer Drug Shows 33% Response Rate in Melanoma Trial Data | MURA Stock News - StockTitan

Nov 20, 2024

Nov 18, 2024

HC Wainwright Raises Earnings Estimates for Mural Oncology - Defense World

Nov 18, 2024

Nov 18, 2024

HC Wainwright Predicts Stronger Earnings for Mural Oncology - MarketBeat

Nov 18, 2024

Nov 16, 2024

MURAMural Oncology plc Ordinary Shares Latest Stock News & Market Updates - StockTitan

Nov 16, 2024

Nov 15, 2024

Armistice Capital, LLC Increases Stake in Mural Oncology PLC - GuruFocus.com

Nov 15, 2024

Nov 13, 2024

Mural Oncology Announces Third Quarter 2024 Financial Results and Provides Update on Pipeline Progress - The Manila Times

Nov 13, 2024

Nov 13, 2024

Mural Oncology plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 13, 2024

Nov 13, 2024

Mural Oncology Reports 38% Lower Net Loss, Hits Trial Enrollment Milestones in Q3 | MURA Stock News - StockTitan

Nov 13, 2024

Nov 11, 2024

HC Wainwright Reaffirms "Buy" Rating for Mural Oncology (NASDAQ:MURA) - MarketBeat

Nov 11, 2024

Nov 11, 2024

Mural Oncology to Participate in Two Upcoming Investor Conferences - The Manila Times

Nov 11, 2024

Nov 11, 2024

Mural Oncology (MURA) to Present at Major Healthcare Investor Conferences | MURA Stock News - StockTitan

Nov 11, 2024

Nov 08, 2024

Mural Oncology Presents Clinical and Preclinical Data Across its Pipeline at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) - The Manila Times

Nov 08, 2024

Nov 07, 2024

Mural Oncology Reports Promising Cancer Trial Data, Plans Key 2025 Readouts | MURA Stock News - StockTitan

Nov 07, 2024

Nov 05, 2024

Vanguard Group Inc's Strategic Reduction in Mural Oncology PLC H - GuruFocus.com

Nov 05, 2024

Nov 01, 2024

Mural Oncology CFO Adam Cutler sells $25,305 in company stock By Investing.com - Investing.com Canada

Nov 01, 2024

Nov 01, 2024

Mural Oncology plc (NASDAQ:MURA) CFO Adam D. Cutler Sells 7,421 Shares - MarketBeat

Nov 01, 2024

Nov 01, 2024

Mural Oncology CFO Adam Cutler sells $25,305 in company stock - Investing.com

Nov 01, 2024

Oct 28, 2024

Short Interest in Mural Oncology plc (NASDAQ:MURA) Decreases By 15.7% - MarketBeat

Oct 28, 2024

Oct 21, 2024

HC Wainwright Comments on Mural Oncology Q3 Earnings - MarketBeat

Oct 21, 2024

Oct 17, 2024

Mural Oncology (NASDAQ:MURA) Coverage Initiated at HC Wainwright - MarketBeat

Oct 17, 2024

Oct 17, 2024

H.C. Wainwright initiates coverage on Mural Oncology stock with Buy rating - Investing.com UK

Oct 17, 2024

Oct 10, 2024

167,644 Shares in Mural Oncology plc (NASDAQ:MURA) Bought by Squarepoint Ops LLC - MarketBeat

Oct 10, 2024

Oct 09, 2024

232,100 Shares in Mural Oncology plc (NASDAQ:MURA) Bought by Renaissance Technologies LLC - MarketBeat

Oct 09, 2024

Oct 07, 2024

Mural Oncology to Present Clinical and Preclinical Data at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) - The Manila Times

Oct 07, 2024

Oct 04, 2024

Raymond James Begins Coverage on Mural Oncology (NASDAQ:MURA) - Defense World

Oct 04, 2024

Oct 04, 2024

Mural Oncology (NASDAQ:MURA) Coverage Initiated by Analysts at Raymond James - MarketBeat

Oct 04, 2024

Oct 04, 2024

This MINISO Group Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga

Oct 04, 2024

Oct 02, 2024

Rhumbline Advisers Makes New $34,000 Investment in Mural Oncology plc (NASDAQ:MURA) - Defense World

Oct 02, 2024

Oct 01, 2024

Point72 Asia Singapore Pte. Ltd. Invests $84,000 in Mural Oncology plc (NASDAQ:MURA) - Defense World

Oct 01, 2024

Sep 30, 2024

Mural Oncology Highlights Clinical Trials During It's Maiden Investor Day - Forbes

Sep 30, 2024

Sep 28, 2024

Armistice Capital LLC Takes Position in Mural Oncology plc (NASDAQ:MURA) - Defense World

Sep 28, 2024

Sep 27, 2024

1,688,000 Shares in Mural Oncology plc (NASDAQ:MURA) Acquired by Armistice Capital LLC - MarketBeat

Sep 27, 2024

Sep 26, 2024

Mural Oncology's First Virtual Investor Day to Highlight Late-Stage Clinical Progress - The Manila Times

Sep 26, 2024

Sep 26, 2024

Mural Oncology’s First Virtual Investor Day to Highlight Late-Stage Clinical Progress - StockTitan

Sep 26, 2024